Naurex
Part of AbbVie
Organization
Trials
Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)
Phase 3, Withdrawn, 0 people, Feb 27, 2019
Assessment of Effect of Rapastinel on Driving Performance
Phase 1, Completed, 107 people, Jan 24, 2019
Assessment of Abuse Potential of Rapastinel in Humans
Phase 1, Completed, 72 people, Jan 10, 2019
Sources: clinicaltrials.gov
Named in competing interests
Consulting or advice, Fees or honoraria, Dec 5, 2025
Age or age of onset: which is the best criterion to classify late-life depression?
Consulting or advice, Fees or honoraria, Mar 21, 2023
A comparison of methods to harmonize cortical thickness measurements across scanners and sites
Consulting or advice, Board or leadership role, Jul 30, 2022
Sources: pubmed.ncbi.nlm.nih.gov